UNH Stock Ownership Activity

UNITEDHEALTH GROUP INC 13F holders

12 value investing gurus have made changes to the UNITEDHEALTH GROUP INC (UNH) position according to the gurus' latest SEC quarterly report(s). UNH has been completely sold out by 1 guru(s), the number of UNH shares has been increased by 2, decreased by 9 super investor(s).

Which gurus or hedge funds are buying UNH now?

According to the latest SEC filing(s) UNITEDHEALTH GROUP INC (UNH) has been bought by 2 gurus: Robert Olstein - Olstein Capital Management (added shares +93.33%) and Ronald Muhlenkamp - Muhlenkamp & Co (added shares +1.15%).

To see more about who is investing in UNITEDHEALTH GROUP INC (UNH), please go to the UNH ownership page.

2023 Q1 (12 results)
Francois Rochon
-100.00%
-1,733
-0.06%
0.00%
John Armitage
-91.60%
-974,662
-4.97%
0.00%
Daniel Loeb
-50.00%
-335,000
-2.59%
0.00%
Stephen Mandel
-16.21%
-172,433
-0.75%
3.90%
Glenn Greenberg
-8.29%
-100
-0.00%
0.02%
Ravenel Boykin Curry IV
-8.26%
-180,603
-0.39%
4.32%
Eric H. Schoenstein
-3.38%
-47,090
-0.17%
4.99%
David M. Polen
-0.48%
-13,041
-0.02%
3.38%
Paul Lountzis
+7.03%
+819
+0.23%
3.49%
David Rolfe
+24.09%
+14,606
+1.17%
6.03%
Robert Olstein
+41.94%
+3,250
+0.24%
0.81%
Ole Andreas Halvorsen
+65.65%
+832,288
+1.85%
4.68%
Current price: $484.11 2.49% AVG reported price*: $472.35
2022 Q4 (14 results)
Glenn Greenberg
-51.09%
-1,260
-0.02%
0.02%
Ravenel Boykin Curry IV
-24.94%
-726,183
-1.83%
5.49%
Robert Olstein
-10.92%
-950
-0.08%
0.64%
John Armitage
-7.44%
-85,473
-0.39%
4.85%
V. D. Dodge, E. M. Cox
-6.15%
-148,300
-0.09%
1.39%
David M. Polen
-4.35%
-123,918
-0.19%
4.22%
Andrew R. Adams
-1.56%
-8,000
-0.10%
6.20%
David Rolfe
-0.40%
-245
-0.02%
5.90%
Ronald Muhlenkamp
+0.08%
+19
+0.00%
5.56%
Paul Lountzis
+0.13%
+15
+0.00%
3.33%
Stephen Mandel
+13.21%
+124,144
+0.63%
5.38%
Eric H. Schoenstein
+15.38%
+185,736
+0.77%
5.78%
Ole Andreas Halvorsen
+263.71%
+919,153
+2.45%
3.38%
Francois Rochon
buy
+1,733
+0.06%
0.00%
Current price: $484.11 8.01% AVG reported price*: $526.25
2022 Q4 (1 result)
Ruane, Cunniff & Goldfarb
-17.06%
-79,350
-1.45%
7.03%
Current price: $484.11 8.69% Reported price*: $530.18
2022 Q3 (13 results)
John Armitage
-23.23%
-347,821
-1.36%
4.51%
Robert Olstein
-13.00%
-1,300
-0.11%
0.74%
Andrew R. Adams
-4.99%
-27,000
-0.32%
6.14%
V. D. Dodge, E. M. Cox
-2.97%
-73,900
-0.05%
1.57%
David Rolfe
-2.59%
-1,619
-0.15%
5.78%
Paul Lountzis
-2.33%
-278
-0.10%
3.99%
David M. Polen
-2.30%
-67,080
-0.09%
4.03%
Ronald Muhlenkamp
+0.86%
+212
+0.05%
5.58%
Ravenel Boykin Curry IV
+1.45%
+41,703
+0.10%
6.70%
Eric H. Schoenstein
+8.41%
+93,674
+0.41%
5.31%
Stephen Mandel
+17.39%
+139,144
+0.66%
4.47%
Daniel Loeb
+17.54%
+100,000
+0.92%
6.14%
Ole Andreas Halvorsen
buy
+348,550
+0.82%
0.82%
Current price: $484.11 4.14% AVG reported price*: $505.04
40 of 434

Shares, change to shares, sold shares - split-adjusted.

Reported price - this doesn't represent the actual buy or sell price.
It is the split-adjusted price of the security as of the last day of the reported period.

Value or Price - If the security is completely sold out, we show the reported value (or price) prior to the actual period.